文献速递眼底病与葡萄膜炎神经眼科

视网膜糖尿病神经退行性变与2型糖尿病患者糖尿病视网膜病变进展的纵向关系

Longitudinal Relationship Between Retinal Diabetic Neurodegeneration and Progression of Diabetic Retinopathy in Patients With Type 2 Diabetes.
PubMed 文献 · Am J Ophthalmol · 2018-09-07

该回顾性队列研究纳入无DR或轻度NPDR的2型糖尿病患者87眼,随访至少4年,用OCT测量黄斑区神经节细胞-内丛状层(mGCIPL)厚度。结果显示44.8%眼发生2步DR进展、6.9%进展为PDR;基线mGCIPL厚度、mGCIPL变薄速率、心脏自主神经病变评分及周围神经传导速度是DR进展的显著预测因素,AUC为0.92。

要点

  • mGCIPL进行性变薄是早期DR进展的独立危险因素。
  • 基线mGCIPL厚度、变薄速率、CAN评分及神经传导速度可预测DR进展,AUC=0.92。
  • 评估自主神经和周围神经功能可提高预测T2DM患者DR加重的敏感性。

核心结论

  • mGCIPL进行性丢失是早期DR进展的独立危险因素。
  • 进一步评估自主神经和周围神经功能可提高预测T2DM患者DR加重的敏感性。

研究设计与样本

  • 回顾性队列研究,纳入无DR或轻度NPDR的T2DM患者,随访至少4年。
  • 共分析87眼,DR按视网膜照相分级,用OCT测量黄斑旁中心mGCIPL平均厚度,基线后至少间隔6个月。
  • 采用Cox比例风险模型基于基线临床因素计算预测2步DR进展和PDR发生的风险比(HR)。

主要发现

  • 87眼中39眼(44.8%)发生2步DR进展,6眼(6.9%)进展为PDR。
  • DR进展患者具有更长的T2DM病程、更薄的mGCIPL、更大的mGCIPL变薄速率、更严重的CAN、更低的周围神经传导速度和更高的HbA1c水平。
  • 多因素回归显示基线mGCIPL厚度(HR=0.94)、mGCIPL变薄速率(HR=1.924)、CAN评分(HR=1.248)和周围神经传导速度(HR=0.894)是DR进展的显著预测因素,AUC=0.92。

关键数值与推荐

  • 基线mGCIPL厚度HR=0.94,mGCIPL变薄速率HR=1.924,CAN评分HR=1.248,周围神经传导速度HR=0.894,均预测DR进展。
  • 联合模型预测DR进展的AUC=0.92。

临床怎么用

  • 对无DR或轻度NPDR的T2DM患者,可纵向监测mGCIPL厚度及其变薄速率以评估DR进展风险。
  • 结合自主神经和周围神经功能评估可提高DR加重预测的敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the longitudinal relationship between diabetic retinal neurodegeneration and the progression of diabetic retinopathy (DR) by measuring macular ganglion cell-inner plexiform layer (mGCIPL) thickness in patients with type 2 diabetes (T2DM). DESIGN: Retrospective cohort study. METHODS: T2DM patients with no DR or mild nonproliferative DR (NPDR) followed up for ≥4 years were included in this study. DR was graded according to retinal photography, and mean parafoveal mGCIPL thickness was measured using optical coherence tomography with at least a 6-month interval from baseline. Hazard ratios (HR) for predicting 2-step progression and development of proliferative DR (PDR) were calculated using Cox proportional hazard modeling using baseline clinical factors. RESULTS: Of 87 eyes of T2DM patients, 39 (44.8%) exhibited 2-step DR progression and 6 (6.9%) experienced progression to PDR. Patients with DR progression exhibited longer T2DM duration, thinner mGCIPL, greater mGCIPL thinning rate, severe cardiac autonomic neuropathy (CAN), lower peripheral nerve-conduction velocity, and higher glycated hemoglobin A1c level. Multivariate regression modeling revealed that baseline mGCIPL thickness (HR = 0.94), mGCIPL thinning rate (HR = 1.924), CAN score (HR = 1.248), and conduction velocity of peripheral nerves (HR = 0.894) were significant predictive factors for DR progression (area under the curve = 0.92). CONCLUSION: Progressive loss of mGCIPL is an independent risk factor for progression in early-stage DR. Further assessment of autonomic and peripheral nerve functions can increase sensitivity in predicting aggravation of DR in patients with T2DM.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kim K, Kim ES, Yu SY, et al. Longitudinal Relationship Between Retinal Diabetic Neurodegeneration and Progression of Diabetic Retinopathy in Patients With Type 2 Diabetes. Am J Ophthalmol. 2018. PMID: 30195892. doi:10.1016/j.ajo.2018.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。